Rabbit Anti-Human PlGF (Peptide)
Slide this table
| Cat-Nr. | 102-PA01S |
| Size | 100 µg |
| Price | 170 € |
| Category | Polyclonal Antibody |
| Clone Nr. | Rabbit IgG |
| Species Reactivity | Human |
| Formulation | lyophilized |
| Buffer | PBS |
| Reconstitution | Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml. |
| Stability and Storage | The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots. |
| Preparation | Produced from sera of rabbits immunized with a highly purified N-terminal peptide of human PlGF (placenta growth factor). Anti-PlGF was purified by affinity chromatography with immobilized Protein A. |
| Antigen | N-terminal peptide (20aa) of native human PlGF |
| Application | WB, E, IF |
| Synonyms | PlGF; placental growth factor |
| Description | Placenta growth factor (PlGF) is a member of the PDGF/VEGF family of growth factors that share a conserved pattern of eight cysteines. Alternate splicing results in at least three human mature PlGF forms containing 131 (PlGF1), 152 (PlGF2), and 203 (PlGF3) amino acids (aa) respectively. Only PlGF2 contains a highly basic heparinbinding 21 aa insert at the C-terminus. In the mouse, only one P lGF that is the equivalent of human PlGF2 has been identified. Human PlGF1 shares 56%, 55%, 74% and 95% aa identity with the appropriate isoform of mouse, rat, canine and equine PlGF. PlGF is mainly found as variably glycosylated, secreted, 55 - 60 kDa disulfide linked homodimers. Mammalian cells expressing PlGF include villous trophoblasts, decidual cells, erythroblasts, keratinocytes and some endothelial cells. Circulating PlGF increases during pregnancy, reaching a peak in mid-gestation; this increase is attenuated in preeclampsia. However, deletion of PlGF in the mouse does not affect development or reproduction. Postnatally, mice lacking PlGF show impaired angiogenesis in response to ischemia. PlGF binds and signals through VEGF R1/Flt1, but not VEGF R2/Flk-1/KDR, while VEGF binds both but signals only through the angiogenic receptor, VEGF R2. PlGF and VEGF therefore compete for binding to VEGF R1, allowing high PlGF to discourage VEGF/VEGF R1 binding and promote VEGF/VEGF R2mediated angiogenesis. However, PlGF (especially PlGF1) and some forms of VEGF can form dimers that decrease the angiogenic effect of VEGF on VEGF R2. PlGF2, but not PLGF-1, shows heparindependent binding of neuropilin (Npn)-1 and Npn2. PlGF induces monocyte activation, migration, and production of inflammatory cytokines and VEGF. These activities facilitate wound and bone fracture healing, but also contribute to inflammation in active sickle cell disease and atherosclerosis. |
| Uniprot ID | P49763 |
| Protein RefSeq | NP_001193941.1 |
| mRNA RefSeq | NM_001207012.1 |
Figures
Western Blot analysis of human PlGF-2 with a polyclonal antibody directed against a N-terminal peptide of native human PlGF. There is a strong cross reactivity with mouse PlGF.
Western Blot analysis of human PlGF isoforms with a polyclonal antibody directed against an N-terminal peptide of native human PlGF. There is a weak cross reactivity with rat PlGF.
Reference
- Proteolytic Processing Regulates Placental Growth Factor Activities. D. C. Hoffmann et al., J Biol Chem. 2013 Jun 21; 288(25): 17976–17989.
- Flt-1 signaling in macrophages promotes glioma growth in vivo. M. Kerber et al., Cancer Res. 2008 Sep 15;68(18):7342-51
- Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. P. Carmeliet et al., Nat Med. 2001 May;7(5):575-83.
All prices plus VAT + possible delivery charges